{
  "nct_id": "NCT04278118",
  "official_title": "HiPPI: A Phase 2 Trial of Hypofractionated Pencil Beam Scanning Proton Therapy for Benign Intracranial Tumors",
  "brief_title": "Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study",
  "cancer_type_display": "A study of hypofractionated proton or photon radiation therapy for benign intracranial brain tumors, including meningiomas, pituitary adenomas, and schwannomas.",
  "cancer_tags": [
    "Grade I Meningioma",
    "Grade II Meningioma",
    "Grade III Meningioma",
    "Intracranial Neoplasm",
    "Nerve Sheath Neoplasm",
    "Pituitary Gland Adenoma",
    "Schwannoma"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT04278118",
  "phase": "NA",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2024-12-13",
  "enrollment": 70,
  "min_age": 18,
  "max_age": null,
  "sex": "ALL",
  "is_metastatic_allowed": false,
  "performance_status_scale": null,
  "performance_status_values": null,
  "min_prior_lines": null,
  "max_prior_lines": null,
  "prior_treatments_required": null,
  "prior_treatments_excluded": [
    "Prior radiation therapy that would overlap with current target volume"
  ],
  "principal_investigator": "Bree R Eaton",
  "site_name": "Emory University Hospital/Winship Cancer Institute",
  "contact_email": "brupper@emory.edu",
  "contact_phone": "404-251-2690",
  "locations": [
    {
      "facility": "Emory University Hospital/Winship Cancer Institute",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "Bree R. Eaton",
          "role": "CONTACT",
          "phone": "404-251-2690",
          "email": "brupper@emory.edu"
        },
        {
          "name": "Bree R. Eaton",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    }
  ],
  "key_inclusion_summary": [
    "Pathologically or radiographically diagnosed benign intracranial or nerve sheath tumor, including meningiomas (WHO grade 1, 2, or 3), pituitary adenomas, and schwannomas.",
    "Recommended to receive proton or photon fractionated radiation therapy.",
    "Age 18 years or older.",
    "Must be able to provide signed informed consent."
  ],
  "key_exclusion_summary": [
    "Pregnant females.",
    "Prior radiation therapy that would overlap with the current target volume.",
    "Inability to undergo magnetic resonance imaging (MRI)."
  ]
}